Trading Signals: ADPT Stock Price Prediction and Forecast (Thu. Jun. 27, 2019 - Wed. Sep. 14, 2022)(Adaptive Biotechnologies Corporation)
| ADPT latest price $38.8900 (-3.02%) ($37.9500 - $40.4000) on Tue. Jul. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.18% (three month average) | RSI | 50 | Latest Price | $38.8900(-3.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADPT advances 30.2% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ADPT advance at 0% a week (0% probability) GDX(7%) IFRA(7%) GDXJ(6%) TLT(6%) BND(5%) | Factors Impacting ADPT price | ADPT will decline at least -7.59% in a week (0% probabilities). KWEB(-9%) FXI(-9%) MCHI(-8%) ONLN(-7%) URA(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -7.59% (StdDev 15.18%) | Hourly BBV | 0 () | Intraday Trend | -2.8% | | | |
|
5 Day Moving Average | $33.52(16.02%) | 10 Day Moving Average | $0(0%) | 20 Day Moving Average | $0(0%) | To recent high | -19.5% | To recent low | 0% | Market Cap | $4.987b | | | | Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA. |